Extramural Research
![Man using virtual reality headset](https://public4.pagefreezer.com:443/content/FDA/01-06-2023T13:38/https://www.fda.gov/files/styles/main_image_medium/public/iStock-1155257412.jpg?itok=Lf2ucK2K)
The Office of Minority Health and Health Equity (OMHHE) Research and Collaboration Program works with external partners to support research studies about minority health and health disparities. Research under this program provides insight into the scientific basis for individual therapies. Studies also provide future directions for research and aid regulatory decision-making.
Sign up to receive OMHHE Enhance Equity Initiative Funding Opportunities updates and for information on available funding opportunities.
Project | Awarded To | Fiscal Year | Funding Mechanism | Status |
---|---|---|---|---|
The Shades of Beauty: Understanding African and Asian American Women's Perceptions of Using Skin Lightening Products and Creating Innovative and Educational Messages | Howard University | 2022 | RFA | On Going |
Develop and Evaluate a Targeted Education Campaign in Northern Manhattan and the South Bronx to Protect West African, South Asian, and Latinx Populations from Hazardous Skin Lightening Products | West Harlem Environmental Action | 2022 | RFA | On Going |
Strengthening FDA’s Ability to Communicate Health and Safety Information to Minority Populations About Pediatric COVID-19Vaccines and Vaccine Boosters Utilizing Social Media Platforms | National Minority Quality Forum | 2022 | BAA | On Going |
Increasing Participation in Clinical Trials and Research in Tribal and Urban Indigenous Communities | American Indian Opportunity | 2022 | BAA | On Going |
Advancing equity through the Alliance for Representative Trials (ARC) program to diversify and bring industry-sponsored trials to communities of color and underrepresented communities | National Minority Quality Forum | 2022 | RFA | On Going |
LatinX/HIspanic Attitudes and Perspectives on Investigations and Studies- of New Drugs (LAPIS-ND) | University of California, San Francisco | 2022 | RFA | On Going |
Examining Predictors of Vaccine Trial Engagement Outcomes among Sexual and Gender Minority LatinX Communities through an Explanatory Mixed Methods Design | Florida State University | 2022 | RFA | On Going |
Examining misinformation correction strategies to encourage clinical trial participation among Black Americans | Indiana State University | 2022 | RFA | On Going |
Utilizing a Lupus Clinical Trials Network to Advance Diversity and Representation in Clinical Trials: Perspectives, Preferences, and Unmet Needs of Patients, Providers, and Stakeholder Agencies | University of North Carolina at Chapel Hill | 2022 | RFA | On Going |
Evaluating Impact of Mobile Community Education Engagement Initiative on Perceptions and Behaviors Related to Clinical Research Among Underserved Populations | Center for Information and Study on Clinical Research Participation (CISCRP) | 2022 | RFA | On Going |
Real-World Accelerator to evolve the standard of Care and Engagement in clinical studies | Reagan-Udall Foundation | 2022 | RFA | On Going |
Multimorbidity and Medications: the unheard perspective of older Under-Represented Racial and Ethnic Minority Adults | University of California, San Francisco | 2022 | RFA | On Going |
Co-creation of digital tools to enhance young adult minority participation in COVID-19 trials | California State University, Fullerton | 2022 | RFA | On Going |
Hispanic, black and pacific islandeR perspectives on COVID-19 oUtreach Strategies and patient centered outcomes (HeAR US) | Queens Medical Center | 2022 | RFA | On Going |
COMmunity Mistrust and Institutional Trustworthiness to advance health EQuity research (COMMIT-EQ) | University of Maryland, Baltimore | 2022 | RFA | On Going |
Center for Advancing COVID-19 Health Equity Research | Florida Agricultural and Mechanical University | 2022 | RFA | On Going |
Utilizing the Pharmacy Advances Clinical Trials (PACT) Network to Achieve Diversity in COVID Clinical Trials: A Strategic Framework | Texas A&M University Health Science Center | 2022 | RFA | On Going |
Bridging Gaps: Recruiting African American and Asian American Participants for COVID-19 Clinical Trials and Creating Culturally Competent Messages | Howard University | 2021 | BAA | On Going |
Improving clinical trial diversity and participation among people living with Chronic Hepatitis B | Hepatitis B Foundation | 2021 | BAA | On Going |
Integrating patient and consumer-generated discursive data to inform and enhance FDA One Health Initiative communication strategies | University of Maryland | 2021 | CERSI | On Going |
Exploring the use of Real-World Data to Generate Real-World Evidence to support COVID-19 treatment outcomes among racial and ethnic minority groups | US Department of Veterans Affairs | 2021 | IAA | On Going |
Using Big Data, Machine Learning, and Infoveillance Approaches to Detect and Characterize Adoptions and Adherence to PrEP Therapy Among Minority Populations | S-3 Research | 2021 | BAA | On Going |
Skin Lightening Products: Understanding Consumer Perspectives and Effective Educational Messages | Reagan-Udall Foundation | 2021 | Cooperative Agreement | On Going |
Understanding Barriers to Hepatitis B Clinical Trials | Hepatitis B Foundation | 2020 | RCA | On Going |
Leveraging Community Engagement and Electronic Health Record Strategies to Promote Diverse Participation in COVID-19 Clinical Trials | Yale University | 2020 | BAA | On Going |
Beyond Clinical Trials: Investments in Real world Evidence and Artificial intelligence for Studying the Safety of DOACs among Veterans | US Department of Veterans Affairs | 2020 | IAA | On Going |
Characterizing Population-Specific Clinical Asthma Profiles | University of California, San Francisco-Stanford University | 2020 | CERSI | On Going |
Usability Testing of Virtual Reality for Pain Management Among Diverse Patients | University of California, San Francisco-Stanford University | 2020 | CERSI | On Going |
Social Listening for Patient Perspectives on Chronic Pain | Inspire | 2019 |
BAA |
Complete |
Safer Medication Use for Children with Chronic Illness | University of California, San Francisco-Stanford University | 2017 | CERSI | Complete |
*Chart information presented from 2017